Holen Sie sich die Stockscreener-App
4.88
2.95%
0.14
Vorhandelsmarkt:
4.67
-0.21
-4.30%
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
CVRx Inc (CVRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CVRx Inc (CVRX) Balance Sheet - TradingKey
CVRx Inc (CVRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CVRx Inc (CVRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CVRX|CVRx Inc|Price:4.740|Chg%:-0.150 - TradingKey
CVRx Inc (CVRX) Cash Flow - TradingKey
CVRX|CVRx Inc|Price:4.815|Chg%:+0.075 - TradingKey
CVRx Inc (CVRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CVRx (CVRX) Q4 2025 earnings summary - Quartr
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026 - The Manila Times
CVRx Plans Aug. 6 Webcast on Second-Quarter Results - Stock Titan
CVRx Inc (CVRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CVRx (CVRX) Proxy filing Summary - Quartr
CVRx partners with Piedmont Columbus Regional Medical Center for first Barostim implant - Traders Union
CVRx (CVRX) The 44th Annual William Blair Growth Stock Conference Summary - Quartr
CVRx (CVRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 Summary - Quartr
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx Inc (CVRX) Stock Forum and Discussion - Moomoo
(CVRX) Risk Channels and Responsive Allocation - Stock Traders Daily
CVRx Inc(CVRX) Stock Options Chain | Quotes & News - Moomoo
CVRX Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Cleveland Clinic Florida adopts Barostim implant in collaboration with CVRx - Traders Union
CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing - Ad-hoc-news.de
CVRx (CVRX) Piper Sandler 36th Annual Healthcare Conference Summary - Quartr
CVRx enables first commercial Barostim implant in Washington state for heart failure treatment - Traders Union
CVRx Inc focuses on cardiovascular innovation amid thin market signals - Ad Hoc News
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and CVRx (CVRX) - The Globe and Mail
CVRX Q1 2026 Earnings: EPS Beats Estimates as Loss NarrowsRevenue Breakdown Analysis - dars.gov.et
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Enterprise value to EBIT forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRX,INVA Volatility & Greeks - Finviz
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
CVRx (CVRX) moves 11.6% higher: Will this strength last? - MSN
CVRX Q1 2026 Earnings: EPS Exceeds Estimates as Company Navigates Market ChallengesMid-Term Outlook - dars.gov.et
CVRx Inc. (CVRX) Sinks 13.5% as Selling Pressure Intensifies Near Key SupportKeltner Channel - dars.gov.et
CVRX Q1 2026 Earnings: EPS Beats Estimates Amid Operational ProgressEarnings Manipulation Risk - dars.gov.et
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last? - Yahoo Finance
CVRx Inc. Surges on Strong Trading Activity; Key Resistance Levels AheadTriple Bottom - dars.gov.et
Price to earnings forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
Enterprise value to revenue forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
Price to book forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRx, Inc. Actuals & Estimates (NASDAQ:CVRX) - TradingView
CVRX Forecast — Price Target — Prediction for 2027 - TradingView
(CVRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
CVRx Inc (CVRX) Institutional Confidence - TradingKey
CVRx stock up on Humana's Medicare coverage for Barostim therapy - MSN
CVRx Inc (CVRX) Stock Forecast & Analyst Ratings - Moomoo
CVRX Q1 2026 Earnings: EPS Beats Estimates as Pre‑Revenue Progress Drives Stock HigherEarnings Quality Analysis - dars.gov.et
CVRx to present Barostim integration strategies at AAHFN Annual Meeting - Traders Union
CVRx Inc (CVRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CVRx Inc (CVRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
CVRx Inc (CVRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Barostim adoption in heart failure management advances, led by CVRx - Traders Union
CVRx partners with Huntsville Hospital for first Barostim implant, expanding device therapy options - Traders Union
CVRx Inc. (CVRX) Gains Ground: Testing Key Resistance After Support BounceTWAP Entry - dars.gov.et
CVRX Q1 2026 Earnings: EPS Beat Slightly Narrows LossReturn On Assets - dars.gov.et
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Context Therapeutics (CNTX) - The Globe and Mail
0.79%
4.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):